Does the arrhythmic risk of patients with ischaemic cardiomyopathy really benefit from revascularisation therapy?
Kallergis
Eleftherios M
EM
Mavrakis
Hercules E
HE
Vardas
Panos E
PE
D001145:Arrhythmias, Cardiac / Q000209:etiology* / Q000517:prevention & control*; D016757:Death, Sudden, Cardiac / Q000453:epidemiology / Q000517:prevention & control*; D017147:Defibrillators, Implantable; D006801:Humans; D017202:Myocardial Ischemia / Q000150:complications* / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy; D009204:Myocardial Revascularization; D018570:Risk Assessment; D017180:Tachycardia, Ventricular / Q000209:etiology / Q000517:prevention & control; D018487:Ventricular Dysfunction, Left / Q000453:epidemiology; D014693:Ventricular Fibrillation / Q000209:etiology / Q000517:prevention & control